Therefore, considering the above-mentioned data, Alzheimer’s disease could be associated not only with an increase in the CX3CL1 ligand, but also in its receptor, supporting the hypothesis of a parallel modification of CX3CL1 and CX3CR1. Here, CX3CR1 is linked to Alzheimer disease.